4//SEC Filing
McHale Duncan 4
Accession 0001694665-22-000017
CIK 0001694665other
Filed
Jan 20, 7:00 PM ET
Accepted
Jan 21, 4:53 PM ET
Size
5.4 KB
Accession
0001694665-22-000017
Insider Transaction Report
Form 4
McHale Duncan
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-01-19+100,000→ 100,000 totalExercise: $5.05Exp: 2032-01-19→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]These options will vest in forty-eight (48) substantially equal installments at the end of each monthly anniversary of the date of grant, subject to continued employment on such dates.
Documents
Issuer
Evelo Biosciences, Inc.
CIK 0001694665
Entity typeother
Related Parties
1- filerCIK 0001738896
Filing Metadata
- Form type
- 4
- Filed
- Jan 20, 7:00 PM ET
- Accepted
- Jan 21, 4:53 PM ET
- Size
- 5.4 KB